CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chromadex Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chromadex Corp
10900 Wilshire Blvd, Suite 600
Phone: (310) 388-6706p:310 388-6706 LOS ANGELES, CA  90024  United States Ticker: CDXCCDXC
Business Summary
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
1400 Mining and quarrying of nonmetallic minerals, except fuels

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Frank L.Jaksch 55 7/1/2022 1/1/2000
Chief Executive Officer, Director Robert N.Fried 64 6/22/2018 7/13/2015
Chief Financial Officer, Principal Accounting Officer OzanPamir 33 10/21/2024 10/21/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ChromaDex 2952 S. Daimler St Santa Ana CA United States

Business Names
Business Name
Asia Pacific Scientific, Inc.
CDI Acquisition, Inc.
CDXC
11 additional Business Names available in full report.

General Information
Number of Employees: 106 (As of 12/31/2023)
Outstanding Shares: 76,383,267 (As of 10/29/2024)
Shareholders: 40
Stock Exchange: NASD
Federal Tax Id: 262940963
Fax Number: (302) 421-5753


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024